Literature DB >> 33670988

Effects of Vitamin D Supplementation on CD4+ T Cell Subsets and mTOR Signaling Pathway in High-Fat-Diet-Induced Obese Mice.

Jeong Hee An1, Da Hye Cho1, Ga Young Lee1, Min Su Kang1, So Jeong Kim1, Sung Nim Han1,2.   

Abstract

Obesity is associated with an impaired balance of CD4+ T cell subsets. Both vitamin D and obesity have been reported to affect the mTOR pathway. In this study, we investigated the effects of vitamin D on CD4+ T cell subsets and the mTOR pathway. Ten-week-old male C57BL/6 mice were divided into four groups and fed diets with different fat (control or high-fat diets: CON or HFD) and vitamin D contents (vitamin D control or supplemented diets: vDC or vDS) for 12 weeks. T cells purified by negative selection were stimulated with anti-CD3/anti-CD28 mAbs and cultured for 48 h. The percentage of CD4+IL-17+ T cells was higher in the vDS than vDC groups. The CD4+CD25+Foxp3+ T cells percentage was higher in HFD than CON groups. The phospho-p70S6K/total-p70S6K ratio was lower in vDS than vDC, but the phospho-AKT/total-AKT ratio was higher in vDS than vDC groups. Hif1α mRNA levels were lower in vDS than vDC groups. These findings suggest HIF1α plays an important role in vitamin-D-mediated regulation of glucose metabolism in T cells, and dietary vitamin D supplementation may contribute to the maintenance of immune homeostasis by regulating the mTOR pathway in T cells.

Entities:  

Keywords:  CD4+ T cell; HIF1α; mTOR pathway; obesity; vitamin D supplementation

Year:  2021        PMID: 33670988      PMCID: PMC7997284          DOI: 10.3390/nu13030796

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  70 in total

1.  Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study.

Authors:  Robin M Daly; Claudia Gagnon; Zhong X Lu; Dianna J Magliano; David W Dunstan; Ken A Sikaris; Paul Z Zimmet; Peter R Ebeling; Jonathan E Shaw
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

2.  IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

Authors:  Luis A Zúñiga; Wen-Jun Shen; Barbara Joyce-Shaikh; Ekaterina A Pyatnova; Andrew G Richards; Colin Thom; Sofia M Andrade; Daniel J Cua; Fredric B Kraemer; Eugene C Butcher
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

3.  Serum metabolite profiles and target tissue gene expression define the effect of cholecalciferol intake on calcium metabolism in rats and mice.

Authors:  James C Fleet; Christy Gliniak; Zhentao Zhang; Yingben Xue; Kathleen B Smith; Rebecca McCreedy; Sunday A Adedokun
Journal:  J Nutr       Date:  2008-06       Impact factor: 4.798

4.  1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.

Authors:  Sneha Joshi; Luiz-Carlos Pantalena; Xikui K Liu; Sarah L Gaffen; Hong Liu; Christine Rohowsky-Kochan; Kenji Ichiyama; Akihiko Yoshimura; Lawrence Steinman; Sylvia Christakos; Sawsan Youssef
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

6.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.

Authors:  Markus Feuerer; Laura Herrero; Daniela Cipolletta; Afia Naaz; Jamie Wong; Ali Nayer; Jongsoon Lee; Allison B Goldfine; Christophe Benoist; Steven Shoelson; Diane Mathis
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

7.  PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ.

Authors:  Yutaka Kurebayashi; Shigenori Nagai; Ai Ikejiri; Masashi Ohtani; Kenji Ichiyama; Yukiko Baba; Taketo Yamada; Shohei Egami; Takayuki Hoshii; Atsushi Hirao; Satoshi Matsuda; Shigeo Koyasu
Journal:  Cell Rep       Date:  2012-03-29       Impact factor: 9.423

8.  mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.

Authors:  Merav Fraenkel; Mali Ketzinel-Gilad; Yafa Ariav; Orit Pappo; Melis Karaca; Julien Castel; Marie-France Berthault; Christophe Magnan; Erol Cerasi; Nurit Kaiser; Gil Leibowitz
Journal:  Diabetes       Date:  2008-01-03       Impact factor: 9.461

Review 9.  The Balance of Th17 versus Treg Cells in Autoimmunity.

Authors:  Gap Ryol Lee
Journal:  Int J Mol Sci       Date:  2018-03-03       Impact factor: 5.923

10.  Adiponectin Limits IFN-γ and IL-17 Producing CD4 T Cells in Obesity by Restraining Cell Intrinsic Glycolysis.

Authors:  Jayagopi Surendar; Stefan J Frohberger; Indulekha Karunakaran; Vanessa Schmitt; Wiebke Stamminger; Anna-Lena Neumann; Christoph Wilhelm; Achim Hoerauf; Marc P Hübner
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

View more
  4 in total

1.  Alteration of Gut Microbiome and Correlated Amino Acid Metabolism Contribute to Hyperuricemia and Th17-Driven Inflammation in Uox-KO Mice.

Authors:  Siyue Song; Yu Lou; Yingying Mao; Xianghui Wen; Moqi Fan; Zhixing He; Yang Shen; Chengping Wen; Tiejuan Shao
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

Review 2.  Your Regulatory T Cells Are What You Eat: How Diet and Gut Microbiota Affect Regulatory T Cell Development.

Authors:  Jian Tan; Jemma Taitz; Shir Ming Sun; Lachlan Langford; Duan Ni; Laurence Macia
Journal:  Front Nutr       Date:  2022-04-20

Review 3.  Interrelationship between Vitamin D and Calcium in Obesity and Its Comorbid Conditions.

Authors:  Iskandar Azmy Harahap; Jean-François Landrier; Joanna Suliburska
Journal:  Nutrients       Date:  2022-08-03       Impact factor: 6.706

4.  Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis.

Authors:  Simseok A Yuk; Hyungjun Kim; Nader S Abutaleb; Alexandra M Dieterly; Maie S Taha; Michael D Tsifansky; L Tiffany Lyle; Mohamed N Seleem; Yoon Yeo
Journal:  Sci Adv       Date:  2021-08-06       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.